SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CVTX - CV Therapeutics, Inc.
An SI Board Since January 1999
Posts SubjectMarks Bans
411 31 0
Emcee:  Todd N. Weisrock Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
86anybody have an estimate of annual sales of Ranexa and when marketing could begilimit-7/9/2003
85CV Therapeutics (ticker: CVTX, exchange: NASDAQ) News Release - 7-Jul-2003 ---Joyce Yee-7/7/2003
84CV Therapeutics Inc (NasdaqNM: CVTX) filed an 8-K on 7/3, in which the Company rmopgcw-7/4/2003
83CV Thera To Go Ahead With $100M Private Offering DOW JONES NEWSWIRES PALO ALTOmopgcw-6/16/2003
82Looks like I sold a day early. alas.mopgcw-5/30/2003
81Thanks WE, (LLC) <<The =2.9 msec mean increase in QT interval…>> SMiljenko Zuanic-5/30/2003
80<i>There is much more, as QLT was examined for three compounds based on thkeokalani'nui-5/30/2003
79I am bit lazy. Does anyone know what prolongation time we are talking here? PreMiljenko Zuanic-5/29/2003
78TWST April 28, 2003-- MPM Capital In an in-depth (6,700 words) Interview, Kurt mopgcw-4/29/2003
77CV Therapeutics Reports 2003 First Quarter Financial Results Wednesday April 16mopgcw-4/16/2003
76CARISA Sub-Analysis of Ranexa(TM) in Angina Patients With Diabetes Shows Increasmopgcw-4/8/2003
75Wellington has a basis of over $30?? DJ CV Therapeutics Ends Pact With Acqua Wemopgcw-4/8/2003
74Lehman starts coverage at equal weight. analyst rich birchenough. no price tarmopgcw-3/6/2003
73FDA Accepts Ranexa(TM) New Drug Application for Filing PALO ALTO, Calif., Marchnigel bates-3/5/2003
72Lehman starts coverage w/ equal weight price target of $23mopgcw-2/10/2003
71CV Therapeutics Selling 378,089 Shares Under Pact >CVTX Dow Jones News Servimopgcw-1/29/2003
70I was impressed by the presentation at H&Q. I've just seen a report by A.J. Mullen-1/21/2003
69Ranexa(TM) Terminated Ventricular Tachycardias in Preclinical Study Potent Inhibmopgcw-1/17/2003
68CVTX has been an excellent trader, but this maybe changing with the FDA ranexa sJoyce Yee-1/11/2003
67Is anyone trading this stock between $18+ and $20+?? seems to consistently cyclemopgcw-1/10/2003
66and yet the stock continues to fall...mopgcw-12/30/2002
65PALO ALTO, Calif., Dec. 30 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdnigel bates-12/30/2002
64Message 18275364mopgcw-11/26/2002
63thanks! (eom)scaram(o)uche-11/22/2002
6213:31 ET CVTX -9% weakness blamed on Ranolazine side effect concerns -- rumoDoc Bones-11/22/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News